Oluwaseyi Dina
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management 7
- Rheumatology top 5%
- Spondyloarthritis Studies and Treatments 12
- Rheumatoid Arthritis Research and Therapies 6
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research 9
-
- Atrial Fibrillation Management and Outcomes 17
- Cardiac Arrhythmias and Treatments 12
-
- Psoriasis: Treatment and Pathogenesis 4
-
- Fibromyalgia and Chronic Fatigue Syndrome Research 4
- Co-authors
- Jack MardekianAllison KeshishianLisa RosenblattJeffrey TrocioQisu ZhangLisy WangLara FallonCunshan Wang
- Journals
- Journal of the American College of Cardiology (1 paper)European Heart Journal (1 paper)Annals of the Rheumatic Diseases (3 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Oluwaseyi Dina
29 papers receiving 471 citations
Hit Papers
Peers
Comparison fields: 5 of 52
- Internal Medicine 103
- Rheumatology 207
- Hematology 108
- Cardiology and Cardiovascular Medicine 215
- Immunology 115
Countries citing papers authored by Oluwaseyi Dina
This map shows the geographic impact of Oluwaseyi Dina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oluwaseyi Dina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oluwaseyi Dina more than expected).
Fields of papers citing papers by Oluwaseyi Dina
This network shows the impact of papers produced by Oluwaseyi Dina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oluwaseyi Dina. The network helps show where Oluwaseyi Dina may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Oluwaseyi Dina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 15 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 10 | |
| 8 | Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled studybreakdown → | 2021 | 159 |
| 9 | 2021 | 7 | |
| 10 | 2021 | 1 | |
| 11 | 2020 | 7 | |
| 12 | 2019 | 18 | |
| 13 | 2019 | 4 | |
| 14 | 2019 | 14 | |
| 15 | 2018 | 20 | |
| 16 | 2018 | 4 | |
| 17 | 2018 | 27 | |
| 18 | 2018 | 1 | |
| 19 | 2017 | 2 | |
| 20 | 2016 | 12 |
About Oluwaseyi Dina
Oluwaseyi Dina is a scholar working on Internal Medicine, Hematology and Rheumatology, having authored 30 papers that have together received 476 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (17 papers), Cardiac Arrhythmias and Treatments (12 papers), Spondyloarthritis Studies and Treatments (12 papers), Autoimmune and Inflammatory Disorders Research (9 papers), Venous Thromboembolism Diagnosis and Management (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). The work is most often cited by research in Internal Medicine (103 citations), Rheumatology (207 citations) and Hematology (108 citations). Oluwaseyi Dina has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Jack Mardekian, Allison Keshishian, Lisa Rosenblatt, Jeffrey Trocio, Qisu Zhang, Lisy Wang, Lara Fallon, Cunshan Wang, Joseph Wu and Dona Fleishaker. Their work appears in journals such as Journal of the American College of Cardiology, European Heart Journal and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.